The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer’s Disease in Chinese Han Population
暂无分享,去创建一个
W. Xu | Jun Xu | Ying Wang | Huidong Tang | Yulei Deng | Ru-jing Ren | Gang Wang | W. Niu | Jianfang Ma | Yiwen Wu | Jialin C. Zheng | Shengdi Chen | Jianqing Ding
[1] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[2] N. Tommerup,et al. Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein* , 1996, The Journal of Biological Chemistry.
[3] D. Price,et al. Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.
[4] H. Schaller,et al. Identification and characterization of SorCS, a third member of a novel receptor family. , 1999, Biochemical and biophysical research communications.
[5] I. Hermans-Borgmeyer,et al. SorCS1, a member of the novel sorting receptor family, is localized in somata and dendrites of neurons throughout the murine brain , 2001, Neuroscience Letters.
[6] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[7] J. Ashford,et al. Non-familial Alzheimer's disease is mainly due to genetic factors. , 2002, Journal of Alzheimer's disease : JAD.
[8] Daniel O. Stram,et al. Modeling and E-M Estimation of Haplotype-Specific Relative Risks from Genotype Data for a Case-Control Study of Unrelated Individuals , 2003, Human Heredity.
[9] N. Laird,et al. Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.
[10] J. Regula,et al. Reconstitution of γ-secretase activity , 2003, Nature Cell Biology.
[11] J. Regula,et al. Reconstitution of gamma-secretase activity. , 2003, Nature cell biology.
[12] H. Schaller,et al. The three sorCS genes are differentially expressed and regulated by synaptic activity , 2004, Journal of neurochemistry.
[13] S. Gandy,et al. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. , 2005, The Journal of clinical investigation.
[14] B. Hyman,et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Gandy,et al. The role of cerebral amyloid β accumulation in common forms of Alzheimer disease , 2005 .
[16] A. Levey,et al. The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments , 2006, The Journal of Neuroscience.
[17] K. Jellinger,et al. Alzheimer 100 – highlights in the history of Alzheimer research , 2006, Journal of Neural Transmission.
[18] A. Klug,et al. Tau protein, the paired helical filament and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[19] S. Small,et al. Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.
[20] J. Nyengaard,et al. Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA , 2007, Molecular and Cellular Biology.
[21] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[22] R. Tanzi,et al. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.
[23] Stephan Züchner,et al. Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10 , 2009, Human mutation.
[24] S. Heath,et al. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. , 2010, Journal of Alzheimer's disease : JAD.
[25] S. Small,et al. Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10-domain protein, SorL1 , 2010, Molecular Neurodegeneration.
[26] J. Haines,et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk , 2011, Annals of neurology.
[27] Richard Mayeux,et al. Impact of Genetic Variation in SORCS1 on Memory Retention , 2011, PloS one.
[28] V. Pankratz,et al. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study , 2011, Molecular Neurodegeneration.
[29] R. Tanzi,et al. RNAi-mediated knock-down of Dab and Numb attenuate Aβ levels via γ-secretase mediated APP processing , 2012, Translational Neurodegeneration.
[30] G. Wang,et al. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease , 2012, Human Genetics.
[31] S. Gauthier,et al. Prevention strategies for Alzheimer’s disease , 2012, Translational Neurodegeneration.
[32] L. Tan,et al. SORCS1 and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in a Northern Han Chinese population , 2012, Brain Research.